Literature DB >> 18395903

A combination therapy of ethanol injection and radiofrequency ablation under general anesthesia for the treatment of hepatocellular carcinoma.

Kazutaka Kurokohchi1, Seishiro Watanabe, Hirohito Yoneyama, Akihiro Deguchi, Tsutomu Masaki, Takashi Himoto, Hisaaki Miyoshi, Hamdy-Saad Mohammad, Akira Kitanaka, Tomohiko Taminato, Shigeki Kuriyama.   

Abstract

AIM: To summarize the effects of laparoscopic ethanol injection and radiofrequency ablation (L-EI-RFA), thoracoscopic (T-EI-RFA) and open-surgery assisted EI-RFA (O-EI-RFA) under general anesthesia for the treatment of hepatocellular carcinoma (HCC).
METHODS: Time-lag performance of RFA after ethanol injection (Time-lag PEI-RFA) was performed in all cases. The volume of coagulated necrosis and the applied energy for total and per unit volume coagulated necrosis were examined in the groups treated under general (group G) or local anesthesia (group L).
RESULTS: The results showed that the total applied energy and the applied energy per unit volume of whole and marginal, coagulated necrosis were significantly larger in group G than those in the group L, resulting in a larger volume of coagulated necrosis in the group G. The rate of local tumor recurrence within one year was extremely low in group G.
CONCLUSION: These results suggest that EI-RFA, under general anesthesia, may be effective for the treatment of HCC because a larger quantity of ethanol and energy could be applied during treatment under painfree condition for the patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18395903      PMCID: PMC2701524          DOI: 10.3748/wjg.14.2037

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  Successful laparoscopic radiofrequency ablation of hepatocellular carcinoma adhered to the mesentery after transcatheter arterial embolization.

Authors:  Kazutaka Kurokohchi; Tsutomu Masaki; Takashi Himoto; Akihiro Deguchi; Seiji Nakai; Hirohito Yoneyama; Shuhei Yoshida; Yasuhiko Kimura; Hideyuki Inoue; Fumihiko Kinekawa; Akira Yoshitake; Kunihiko Izuishi; Seishiro Watanabe; Shigeki Kuriyama
Journal:  Oncol Rep       Date:  2005-01       Impact factor: 3.906

2.  Thoracoscopic ethanol injection and radiofrequency ablation for the treatment of hepatocellular carcinoma located immediately under the diaphragm.

Authors:  Kazutaka Kurokohchi; Shunichi Hirai; Tomohiro Ohgi; Masahiro Ono; Akira Yoshitake; Kazuo Ebara; Yasuhiro Kitamura; Yoshitaka Kasai; Tsuyoshi Maeta; Takaaki Kiuchi; Tsutomu Masaki; Hirohito Yoneyama; Fumikazu Kohi; Shigeki Kuriyama
Journal:  Int J Oncol       Date:  2006-08       Impact factor: 5.650

Review 3.  New aspects of diagnosis and therapy of hepatocellular carcinoma.

Authors:  J Bruix; A J Hessheimer; A Forner; L Boix; R Vilana; J M Llovet
Journal:  Oncogene       Date:  2006-06-26       Impact factor: 9.867

4.  Percutaneous radiofrequency ablation of pulmonary tumors--is there a difference between treatment under general anaesthesia and under conscious sedation?

Authors:  R T Hoffmann; T F Jakobs; A Lubienski; A Schrader; C Trumm; M F Reiser; T K Helmberger
Journal:  Eur J Radiol       Date:  2006-05-26       Impact factor: 3.528

5.  Comparison between combination therapy of percutaneous ethanol injection and radiofrequency ablation and radiofrequency ablation alone for patients with hepatocellular carcinoma.

Authors:  Kazutaka Kurokohchi; Seishiro Watanabe; Tsutomu Masaki; Naoki Hosomi; Yoshiaki Miyauchi; Takashi Himoto; Yasuhiko Kimura; Seiji Nakai; Akihiro Deguchi; Hirohito Yoneyama; Shuhei Yoshida; Shigeki Kuriyama
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

6.  Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study.

Authors:  M Koda; Y Murawaki; A Mitsuda; K Oyama; K Okamoto; Y Idobe; T Suou; H Kawasaki
Journal:  Cancer       Date:  2001-09-15       Impact factor: 6.860

7.  Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis.

Authors:  S A Curley; F Izzo; L M Ellis; J Nicolas Vauthey; P Vallone
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

8.  Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions.

Authors:  T Livraghi; S N Goldberg; S Lazzaroni; F Meloni; T Ierace; L Solbiati; G S Gazelle
Journal:  Radiology       Date:  2000-03       Impact factor: 11.105

9.  Percutaneous radiofrequency ablation therapy with combined angiography and computed tomography assistance for patients with hepatocellular carcinoma.

Authors:  T Yamasaki; F Kurokawa; H Shirahashi; N Kusano; K Hironaka; K Okita
Journal:  Cancer       Date:  2001-04-01       Impact factor: 6.860

10.  Time-lag performance of radiofrequency ablation after percutaneous ethanol injection for the treatment of hepatocellular carcinoma.

Authors:  Kazutaka Kurokohchi; Tsutomu Masaki; Seishiro Watanabe; Seiji Nakai; Akihiro Deguchi; Asahiro Morishita; Hirohito Yoneyama; Tomohiro Ohgi; Masahiro Ono; Akira Yoshitake; Takeshi Kako; Naoko Ohmachi; Takaaki Kiuchi; Tsuyoshi Maeta; Mitsuo Yoshida; Yoshihiro Mori; Fumikazu Kohi; Shigeki Kuriyama
Journal:  Int J Oncol       Date:  2006-04       Impact factor: 5.650

View more
  4 in total

1.  A measure to assess the ablative margin using 3D-CT image fusion after radiofrequency ablation of hepatocellular carcinoma.

Authors:  Hui Tang; Yunqiang Tang; Jian Hong; Tiejun Chen; Cong Mai; Peng Jiang
Journal:  HPB (Oxford)       Date:  2014-10-24       Impact factor: 3.647

2.  Recent advances in radiofrequency ablation for the management of hepatocellular carcinoma.

Authors:  Takashi Himoto; Kazutaka Kurokohchi; Seishiro Watanabe; Tsutomu Masaki
Journal:  Hepat Mon       Date:  2012-10-10       Impact factor: 0.660

3.  Laparoscopic ablation of hepatocellular carcinoma in cirrhotic patients unsuitable for liver resection or percutaneous treatment: a cohort study.

Authors:  Umberto Cillo; Alessandro Vitale; Davide Dupuis; Stefano Corso; Daniele Neri; Francesco D'Amico; Enrico Gringeri; Fabio Farinati; Valter Vincenzi; Giacomo Zanus
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

4.  Incidence and Risk Factors for Liver Abscess After Thermal Ablation of Liver Neoplasm.

Authors:  Xiu-Feng Su; Na Li; Xu-Fang Chen; Lei Zhang; Ming Yan
Journal:  Hepat Mon       Date:  2016-05-23       Impact factor: 0.660

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.